Inhibition of PAF-induced aggregation of human PMNs and platelets by adenosine: in vitro investigations using a newly developed blood filtration system by Nees, S. et al.
Volume 2 1992/1993 
Board of Editors: 
P. Dominiak, Lübeck, Germany 
V.J. Dzau, Stanford, USA 
G. Franz, Regensburg, Germany 
(Managing Editor) 
R. Gröning, Münster, Germany 
H. -D. Höltje, Berlin, Germany 
L H . Hurley, Austin, USA 
C. Melchiorre, Bologna, Italy 
W. A. Ritschel, Cincinnati, USA 
B. Testa, Lausanne, Switzerland 
Μ. Tomoda, Tokyo, Japan 
D. J . Triggle, Buffalo, USA 
Y. Yamori, Izumo, Japan 
11 Springer International 
Contents of volume 2 1992/1993 
No. 1: pp. 1-42 published May 1992 
No. 2: pp. 43-80 published June 1992 
No. 3: pp. 81-122 published August 1992 
No. 4: pp. 123-162 published October 1992 
No. 5: pp. 163-198 published December 1992 
No. 6: pp. 199-240 published Feruary 1993 
Adler J —» Barrett DA 
Allgaier C, Hertting G, Gottstein Ρ: 
Muscarine receptor-mediated regula­
tion of electrically evoked acetyl­
choline release in hippocampus: 
effects of K + channel blockers 191 
Angeli Ρ —> Scapecchi S 
Angeli P, Brasili L, Gulini U , 
Cantalamessa F: Determination of 
muscarinic agonist potencies at Mi 
and M^ receptors in the pithed rat 
207 
Arai I —> Murakami S 
Arakawa R —> Uchida Μ 
Arbogast Η —> Nees S 
Baba Κ—> Murakami S 
Balansard G —> Ollivter Ε 
Ball Β —• Dominiak Ρ 
Barrett DA, Adler J, Nickalls RWD, 
Shaw PN: Microdialysis sampling in 
vitro: the effect on recovery of probe 
length, flow rate and temperature 
139 
Β artel S —> Tenor Η 
Bauer KH—> Sarlikiotis AW 
BebloS—* Becker BF 
Becker BF, Zahler S, Raschke P, 
Schwartz LM, Beblo S: Adenosine 
enhances neutrophil sticking in the 
coronary system: a novel mechanism 
contributing to cardiac reperfusion 
damage 8 
Becker BF, Dominiak P, Schräder J, 
Zimmer H-G: Preface 1 
Behl CR —• Kislaliouglu MS 
Bejeuhr G, Holzgrabe U, Mohr Κ, 
Sürig U, Petersenn A von: Molecular 
modelling and synthesis of potent 
stabilizers of antagonist binding to 
M-cholinoceptors 100 
Betzing J —> Sarlikiotis AW 
Bhalla DV, Kulkarni VM: A three-
component pharmacophore for 
sulphonylurea receptor ligands 163 
Bhatnagar R, Ritschel WA: Pharmaco-
kinetics of dihydrotetrabenazine after 
intravenous and peroral administra-
tion to rats 89 
Bhatnagar R, Ritschel WA: Trans-
dermal feasibility studies of 
dihydrotetrabenazine in rats 92 
Birker Β —> Rose Η 
Blagbrough IS, Daykin M M , 
Doherty M , Pattrick M , Shaw PN: 
Plasma and synovial fluid pharmaco­
kinetics of naproxen in osteo- and 
rheumatoid arthritis in patients: 
relationship to clinical response 70 
Blöchl A—> Dominiak Ρ 
Brasili L—> Angeli Ρ 
Bries D —> Kinget R 
Brune Κ—> Nuernberg Β 
Brunet C—> Cabanis A 
Budd K - ^ Janicki PK 
Bünger R—> Mukohara Ν 
BünningP—» GohlkeP 
Cabanis A, Gressier B, Lebegue S, 
Dine T, Brunet C, Luyckx M , 
Cazin M , Cazin JC: Effects in vitro of 
mesna on the production of some 
reactive oxygen species by human 
neutrophils 236 
Cacini W ^ Z h a n J 
Cagnotto A —> Claudi F 
Canossa M , Ferri S, Romualdi P, 
Melchiorre C: Binding profile of WB 
4101, benoxathian and of their respec-
tive enantiomers at ^-adrenoceptor 
subtypes 77 
Cantalamessa F—> Angeli Ρ 
Capek Ρ —> Nosäl'ovä G 
Catarzi D —> Colotta V 
Cateni F—> Falsone G 
Cazin JC —> Cabanis A 
Cazin Μ —> Cabanis A 
Cecchi L—> Colotta V 
Cingolani GM—> Claudi F 
Claudi F, Cingolani GM, Di Stefano A, 
Giorgioni G, Cagnotto A. Skorupska 
M: Synthesis and evaluation of 
N-n-propyl-N-(2-phenylethyl)-2-
(3-fluoro-4-hydroxyphenyl)ethyl-
amine derivatives as dopamine 
receptor ligands 157 
Colotta V, Cecchi L, Catarzi D, 
Melani F, Filacchioni G, Martini C, 
Tacchi P, Lucacchini A: l-(3-Amino-
phenyl)-3-methyl[l]benzopyrano-
[2,3-c]pyrazol-4-one: a new selective 
A 2 adenosine receptor antagonist 74 
Comte J-H -—> Debord J 
Crespin F—> Ollivier Ε 
Dammer U —> Nees S 
Daniels R, Mittermaier EM: Use of a 
streaming current detector to charac­
terize the complex coacervation of 
gelatin and acacia 123 
Dannhardt G, Schneider G, Schwell Β: 
Identification and 5-lipoxygenase 
inhibiting potency of medicarpin 
isolated from roots of Ononis spinosa 
L. 161 
Daykin MM —> Blagbrough IS 
Debord J, Comte J-H, Lachatre G: 
Partial characterization of a carboxyl-
esterase from guinea pig kidney 166 
Dei S —> Scapecchi S 
Dendorfer A —> Nees S 
Deuticke B: Membrane leakiness 
induced by oxidative damage: 
involvement.-of changes of membrane 
dielectric properties ? 28 
Di Stefano A —• Claudi F 
Diaz Lanza A M —> Ollivier Ε 
Dine Τ—> Cabanis A 
Dirsch V, Wiemann W, Wagner H: 
Antiinflammatory activity of 
triterpene quinone-methides and 
proanthocyanidinsfrom the stem bark 
of Heisteria pallida Engl. 184 
Doherty Μ —> Blagbrough IS 
Dominiak P, Blöchl A, Ball B: Actions 
of converting enzyme inhibitors on 
liver mitochondria of spontaneously 
hypertensive rats (SHR) 20 
Dominiak Ρ —> Becker BF 
Dubey NK —> Mishra A K 
Duhm J, Engelmann Β: N a + - L i + 
countertransport of erythrocytes and 
cardiovascular pathophysiology: the 
lipid hypothesis 32 
Egawa Y —> Suzuki I 
Egawa Y —> Yadomae Τ 
El-Alali A —> Falsone G 
Elias-Jones AC, Larcher VF, Shaw PN: 
An investigation into the relationship 
between liver impairment and 
theophylline pharmacokinetics in 
children 115 
Elias R—> Ollivier Ε 
Engelmann Β —> Duhm J 
Erskine WAR —* Janicki PK 
Falsone G, Cateni F, El-Alali A, 
Papaioannou A, Ravalico L , 
Furlani A: Synthesis of a-chrysan-
themoylmethylen-isatin and y-
lactones with cytostatic activity 104 
Fassihi RA —> Ritschel WA 
Feil F, Tegtmeier M , Hahnemann B, 
Legrum W: Interactions of coumarin-
metabolizing cytochrome Ρ 450 
isozymes with analogues of umbelli-
ferone 43 
Ferri S —> Canossa Μ 
Fetzer J, Folkers G: Temperature 
dependent formation of inclusion 
bodies during the expression of 
recombinant viral thymidine kinase 
112 
Filacchioni G —• Colotta V 
Fischer Y —> Rose Η 
Fleischer J, Moll F: In vitro evaluation 
of drug release from powders 143 
Folkers G —> Fetzer J 
Frick A: Microperfusion studies in the 
inner medullary collecting duct in the 
isolated papilla of the rat kidney: 
evidence for an uptake of S0 4 40 
Furlani A —> Falsone G 
Gerhäuser C, Leonhardt Κ, Tan GT, 
Pezzuto JM, Wagner H : What is the 
active antiviral principle of Thuja 
occidentalis L. ? 127 
Giorgioni G —> Claudi F 
Gohlke P, Unger T, Bünning P: 
Distribution of the angiotensin 
converting enzyme inhibitor 
ramiprilat in the blood vessel wall 
66 
Gohlke Ρ —-> Metsärinne KP 
Gonda R, Tomoda Μ, Takada Κ: The 
core structure and immunological 
activities of ukonan B, the represen­
tative polysaccharide from turmeric, 
and its degradation products 50 
Gottstein Ρ —> Allgaier C 
Gressier Β —> Cabanis A 
Grobecker Η —> Raasch W 
Gualtieri F —> Scapecchi S 
GuliniU—> Angeli Ρ 
Hahnemann Β —> Feil F 
Hamada H, Nakazawa K, Williams HJ, 
Scott A I : A significant increase in 
vindoline content of leaves of 
Catharanthus roseus is induced by UV 
light irradiation 218 
Hartmann RW: Development of a post­
menopausal rat mammary tumor 
model 146 
Hasler A, Meier B: Determination of 
terpenes from Ginkgo biloba L. by 
capillary gas chromatography 187 
Herbots Η —> Kinget R 
Hertting G —> Allgaier C 
Hiltunen R—» Sevon Ν 
Holzgrabe U —> Bejeuhr G 
HondaH-^UchidaM 
Ionescu I —> Rose Η 
Janicki PK, Erskine WAR, Budd K: 
Differences in opioid fractional 
receptor occupancy (FRO) for 
morphine and morphine-6-
glucuronide (M6G) in isolated 
guinea-pig ileum (GPI) in normal and 
morphine-tolerant animals 199 
Kaempfel U , Liefländer Μ: Polysac­
charide covalently linked to the rigid 
layer of the cyanobacterium 
Anabaena variabilis ATCC 29413 
224 
Kammermeier Η —> Rose Η 
Kang Y H —* Mukohara Ν 
Kardosovä A —> Nosäl'ovä G 
Kawakita Τ —> Suzuki I 
Kawakita Τ —> Yadomae Τ 
Kees F—> Raasch W 
Kikuchi S —> Suzuki I 
Kikuchi S —> Yadomae Τ 
Kinget R, Peeters R, Herbots H , 
Bries D: Amylose triacetate as an 
excipient for matrix tablets. I . In vitro 
study 210 
Kislalioglu MS, Sethi PK, Malick AW, 
Behl CR: In vitro iontophoretic 
permeation of a weak base erythro­
mycin from different buffer solutions 
using hairless mouse skin 85 
Kozawa Μ —> Murakami S 
Krause E-G —> Tenor Η 
Kulkarni VM—» Bhalla DV 
Lachatre G —> Debord J 
Larcher VF —> Elias-Jones AC 
Lebegue S —> Cabanis A 
Legrum W —> Feil F 
Lehr Μ: In-vitro assay for the evaluation 
of phospholipase A 2 inhibitors using 
bovine platelets and HPLC with UV-
detection 176 
Leonhardt Κ —> Gerhäuser C 
Liefländer Μ —> Kaempfel U 
Lucacchini A —> Colotta V 
Luyckx Μ —> Cabanis A 
Maillard C Ollivier Ε 
Malick AW—> Kislalioglu MS 
Marchetti NT —» Pazur JH 
Martini C—> Colotta V 
Marucci G —> Scapecchi S 
Meier Β —> Hasler A 
Meier-Ewert Η —> Nees S 
Melani F—> Colotta V · 
Melchiorre C —> Canossa Μ 
Metsärinne KP, Stoll M , Gohlke P, 
Paul M , Unger T: Angiotensin I I is 
antiproliferative for coronary endo-
thelial cells in vitro 150 
Mishra AK, Dubey NK, Mishra L: 
A fungitoxic principle from the leaves 
of Prunus persica 203 
Mishra L —> Mishra AK 
Mishra Y, Ramzan I : Influence of 
Cimetidine and ranitidine on gallamine 
disposition and neuromuscular 
pharmacodynamics in rats 169 
MiskielFJ—• Pazur JH 
Mittermaier EM —> Daniels R 
Miura Ο —> Yadomae Τ 
Mohr Κ—^ Bejeuhr G 
Moll F —> Fleischer J 
Müller-Goymann CC—> Rades Τ 
Mukohara Ν, Kang Y H , Bünger R: 
Magnesium-induced coronary dilation 
and adenosine, α, ß-methylene 
adenosine 5'-diphosphate attenuation 
and theophylline paradox 12 
Murakami S, Arai I , Muramatsu M , 
Otomo S, Baba K, Kozawa M: 
Daphnodorins inhibit gastric H + , 
K+-ATPase and acid secretion 108 
Muramatsu Μ —> Murakami S 
Nagi Ν —> Suzuki I 
Nakazawa Κ —> Hadama Η 
Nees S, Dendorfer A, Meier-Ewert H , 
Strohmenger R, Stiegler Η, Arbogast 
Η, Dammer U , Schönharting Μ: 
Inhibition of PAF-induced aggre­
gation of human PMNs and platelets 
by adenosine: in vitro investigations 
using a newly developed blood 
filtration system 36 
Nickalls RWD —> Barrett DA 
Nomoto Κ —> Suzuki I 
Nomoto Κ —> Yadomae Τ 
Nosäl'ovä G, Strapkovä A, Capek P, 
Kardosovä A: Antitussive activity of 
an a-Z)-glucan isolated from the roots 
of Althaea officinalis L . , var. robusta 
195 
Nuernberg B, Schneider HT, Brune Κ: 
Biliary excretion of salicylates in 
man 135 
OhnoN—> Yadomae Τ 
Oksman-Caldentey K-M —> Sevon Ν 
Okunishi H: Prolonged and tissue-
selective inhibition of vascular 
angiotensin-converting enzyme by 
trandolapril: relevance to its anti­
hypertensive action in spontaneously 
hypertensive rats 180 
Ollivier Ε, Elias R, Maillard C, Diaz 
Lanza A M , Crespin F, Balansard G: 
Biotransformation of polyphenols in 
Hamamelis virginiana leaves 
according to the solvent used for the 
extraction 119 
Olsson RA: A brief history of adenosine 
research 3 
Otomo S —> Murakami S 
Papaioannou A —> Falsone G 
Pattrick M—-> Blagbrough IS 
Paul Μ —> Metsärinne KP 
Pazur JH, Miskiel FJ, Marchetti NT, 
Shiels HR: Sets of isomeric antibodies 
with specificity for the a- and ß-D-
glucose units of glycoconjugates 232 
Petersenn A von —> Bejeuhr G 
Peeters R —> Kinget R 
Pezzuto JM —> Gerhäuser C 
Popping S —> Rose Η 
Raasch W, Grobecker Η, Kees F: 
Influence of ciprofloxacin on brain 
metabolism of biogenic amines in the 
rat 153 
Rades Τ, Müller-Goymann CC: 
Structural investigations on the liquid 
crystalline phases of fenoprofen 131 
Ramzan I —> Mishra Y 
Rao SS, Ritschel WA: Development 
and in vitro/in vivo evaluation of a 
transdermal drug delivery system of 
vasopressin 81 
Raschke Ρ —> Becker BF 
Ravalico L —> Falsone G 
Ritschel WA, Vachharajani NN, 
Fassihi RA: In vitro model optimiza­
tion for antacid evaluation based on 
physiological constraints and human 
gastric pH 58 
Ritschel WA—> Bhatnagar R 
Ritschel WA—> Rao SS 
Ritschel WA —» Zhan J 
Romanelli MN —> Scapecchi S 
Romualdi Ρ —> Canossa Μ 
Rose H , Birker Β, Ionescu I , Popping S, 
Fischer Y, Kammermeier Η: Negative 
inotropic effects of volatile 
anaesthetics and antiarrhythmic drugs 
in cardiomyocytes: analysis of 
contraction and energetics 16 
Sarlikiotis AW, Betzing J, Wohl-
schlegel C, Bauer KH: A new in-vitro 
method for testing colon targeting 
drug delivery systems or excipients 
62 
Scapecchi S, Angeli P, Dei S, Gualtieri F, 
Marucci G, Romanelli MN, Teodori 
E: N,N-diethylaminoethanol and 
N-methyl-4-piperidinol esters of 
2,2-diphenyl-2-ethylthioacetic acid 
as potent and selective muscarinic 
antagonists 220 
Schneider G —> Dannhardt G 
Schneider HT —• Nuernberg Β 
Schönharting Μ —> Nees S 
Schräder J: Regulation of coronary 
blood flow by adenosine 5 
Schräder J-^Becker BF 
Schwartz LM > Becker BF 
Schwell Β —» Dannhardt G 
Scott A I —» Hamada Η 
Sethi PK —> Kislalioglu MS 
Sevon N, Hiltunen R, Oksman-
Caldentey K-M: Chitosan increases 
hyoscyamine content in hairy root 
cultures of Hyoscyamus muticus 96 
Shaw PN —* Barrett DA 
Shaw PN —• Blagbrough IS 
Shaw PN —> Elias-Jones AC 
Shiels HR^Pazu r JH 
Skorupska Μ —> Claudi F 
Stiegler Η —* Nees S 
Stoll Μ—> Metsärinne KP 
Strapkovä A —• Nosäl'ovä G 
Strohmenger R—> Nees S 
Sürig U —> Bejeuhr G 
Suzuki I , Egawa Y, NagiN, Yasuzawa Y, 
Yadomae T, Kawakita T, Kikuchi S, 
Nomoto K: Effects of Chinese herbal 
medicines, saikozai, on antibody 
response and macrophage activities 
214 
Suzuki I —> Yadomae Τ 
TacchiP—»Coletta V 
Takada Κ —> Gonda R 
Tan GT —> Gerhäuser C 
Tegtmeier Μ —> Feil F 
Tenor H , Bartel S, Krause E-G: 
Trapidil, a triazolopyrimidine, 
competes only moderately with 
Aradenosine receptor binding sites 
from brain and heart 47 
Teodori Ε —> Scapecchi S 
Tomoda Μ —> Gonda R 
Uchida M , Arakawa R, Honda H: 
Effects of ambroxol HCl on 
pulmonary surfactant secretion in 
normal and reserpinized rats 173 
UngerT—»GohlkeP 
Unger Τ —> Metsärinne KP 
Vachharajani NN —> Ritschel WA 
Wagner Η —> Dirsch V 
Wagner Η —> Gerhäuser C 
Wiemann W —> Dirsch V 
Williams HJ —* Hamada Η 
Wohlschlegel C—> Sarlikiotis AW 
Yadomae T, Suzuki I , Yasuzawa Y, 
Egawa Y, Ohno N, Kawakita T, 
Kikuchi S, Miura-O, Nomoto K: 
Effect of a traditional herbal 
medicine, jia-wei-gui-pi-tang 
(Japanese name: kami-kihi-to) on the 
antibody responses in mice 228 
Yadomae Τ —» Suzuki I 
Yasuzawa Y —> Suzuki I 
Yasuzawa Y —> Yadomae Τ 
Zahler S —> Becker BF 
Zhan J, Ritschel WA, Cacini W: 
Relation of disposition kinetics to 
anxiolytic effect of intraperitoneal 
administration of carbamazepine in 
rats 54 
Zierhut W, Zimmer H-G: Effects of 
angiotensin converting enzyme 
inhibition on triiodothyronine-
induced cardiac hypertrophy in rats 
24 
Zimmer H-G —> Becker BF 
Zimmer H-G Zierhut W 
Pharm Pharmacol Lett (1992) 2 : 36-39 
) Springer-Verlag 1992 
Inhibition of PAF-induced aggregation of human PMNs 
and platelets by adenosine: in vitro investigations 
using a newly developed blood filtration system 
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Abstract. An innovative filtration system permits the 
quantitative study of humoral and cellular interactions in 
flowing blood under the influence of mediators and in-
hibitors of inflammation. In an initial study it could be 
demonstrated in diluted human whole blood that PAP 
rapidly induced plugging of capillary-sized pores due to 
changes in shape and adhesivity of the PMNs and 
platelets. Adenosine proved to be a potent inhibitor. 
This nucleoside is increasingly produced in PAF-stimu-
lated and filtrated blood, especially after its contact with 
cultured endothelial cells. In conclusion, these observa-
tions contribute to explain why, in the centre of a focus 
of inflammation in vivo, perfusion ceases while hyper-
aemia occurs in the adjacent marginal zone. 
Abbreviations 
PAF: platelet activating factor, FMLP: N-formyl-L-me-
thionyl-L-leucyl-L-phenylalanine, PMN: polymorpho-
nuclear leukocytes, EHNA: erythro-9-(2-hydroxy-3-
nonyl) adenine, CAD: coronary artery disease. 
Introduction 
Although many new insights into the interactions 
between blood cells and the vascular wall in inflamed 
areas have been obtained through the systematic use of 
modern immunological and microscopical techniques, 
many unanswered questions remain, the resolution of 
which requires special in vitro methods that have yet to 
be developed. For example, it is not known to which ex-
tent the reorganisation of inherent leukocytic membrane 
structures or the formation of new ones induced by 
mediators of inflammation might modify the rheological 
behaviour of whole blood. A prompt enhancement of 
the adhesivity or a reduction in the deformability of the 
PMNs brought about in this way could, in particular in 
the early stage of inflammation, contribute greatly 
towards initiating the interaction of these cells with the 
cell adhesion molecules [1] of the stimulated endo-
thelium. Also, not very much is known about the role 
played by the platelets or blood plasma in the early sta-
ges of the inflammatory process. Moreover, until today a 
phenomenon could not be explained that has been 
known to pathologists since the time of R. Virchow, 
namely, while in the centre of a focus of inflammation 
perfusion ceases, hyperaemia develops in the adjacent 
marginal zone. 
Evidence is, however, accumulating to suggest 
that the complex cellular reactions and interactions in 
the vascular bed depend not only on numerous soluble 
activators, but also on inhibitors, and that it is the con-
certed action of all these various influences on all the 
blood cells and the vascular endothelium that decides 
whether the vessels in an organ will be perfused physio-
pressure 
filtrate 
Fig. 1. Schematic diagram of the filtration system. 1: gas cylinder, 
2: electronically regulated pressure device, 3: filtration chamber, 4: 
whole blood, 5: filter (thickness: 10 μηι, pore diameter: 5 μπι), 
6: filtrate detector, 7: computer and plotter 
Correspondence to: S. Nees 
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logically, or whether a thrombotic or inflammatory pro­
cess will develop [2]. 
Unfortunately, accurate biochemical research 
into these interrelationships under in vivo conditions is 
limited by almost insurmountable methodological short­
comings. However, using a specially developed, versatile 
blood filtration system, we can now quantitatively 
measure the cell-specific effects and concentration-
dependent actions of blood cell activators or inhibitors 
in flowing whole blood under largely defined in vitro 
conditions. This is described below for a) PAF, a typical 
inflammation mediator [3], and for b) adenosine which is 
liberated from the endothelial lining of blood vessels or 
produced there by extracellular degradation of adenine 
nucleotides [4]. 
thickness 10 μιη, pore diameter 5 μηι) in a pressure gradient (12 cm 
H^O) kept constant by electronic means. The amount of filtrate was 
continuously determined gravimetrically with the aid of an electronic 
detector, and the results fed on-line to a computer and evaluated in ac­
cordance with the principle shown in Fig. 2. 
After performance of the experiments, the filters were remo­
ved immediately, fixed and histochemically investigated. The influence 
of umbilical vein endothelial cells on the production of adenosine was 
investigated by passing PAF-stimulated blood samples through 
columns (0: 5 mm, length: 2 cm) packed with microbeads (Biosilone, 
Nunc, Roskilde, Denmark) on which confluent layers of this endo­
thelial cell type had been established [5]. Adenosine was analysed 
according to HPLC-standard procedures [6]. 
Results 
Methods 
Venous blood was freshly drawn from healthy donors, anticoagulated 
with citrate, and stored in stoppered and slowly rotated polyethylene 
tubes at 37°C until used. Prior to filtration, the blood samples were 
always diluted to a haematocrit of 6% with a physiologically balanced 
salt solution, and mixed with heparin (9 IU/ml). 
Platelet-rich plasma was obtained by centrifugation of citrated 
blood (10 min at 1,500 rpm, Labofuge, Christ). PMNs were purified 
(95%) with the aid of defined Nycodenz solutions in accordance with 
the instructions of the manufacturer (Nycomed, Torshov, Norway). 
The schematic diagram of the blood filtration system (recently 
developed in cooperation with the company of BOSCH-Wagetechnik 
GmbH, D-7455 Jungingen) is shown in Fig. 1. The blood cells were 
filtered through a polycarbonate filter (Nucleopore, Pleasanton, Calif.; 
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Fig, 2. Principle of the quantitative evaluation of the filtration data. 
Time courses of filtrate accumulation and filtration rate: curves 1 and 
2, respectively; evaluation interval: 3; tangent: 4. A few seconds after 
the onset of filtration, the process is characterized by a phase in which 
a practically constant fraction of the filter pores is being plugged by 
PMNs and/or platelets per unit of time. The duration of this phase 
primarily depends upon the rapidity of activation of these cells, and 
the corresponding flow F through the filter can be described by the 
relationship F = α · e"^ (a: material constant of the filter; ß: plugging 
rate; t: filtration time), ß is determined by the slope of the tangent 
(a/b) drawn to curve 2. Occlusion rate = (l-e~^) χ 100 [%/s] 
Under largely physiological conditions (constant pres­
sure gradients, 37°C, 1.2 mM CaCl 2), heparinized whole 
blood readily passed through the capillary-sized pores of 
the measuring system at an almost constant, high flow 
rate (occlusion rate = 1.3 ± 0.32 %/s, η = 18). After 
preincubation with PAF, in contrast, the pores became 
progressively blocked. The calculated occlusion rate 
revealed a characteristic concentration dependence 
(Fig. 3). Analogous studies performed with purified sus-
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<n 
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ο 
ο 
ο 
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• — # whole blood (ECS 0=1.55 ·10" 7Μ) 
x — χ p M N s (EC 5 0 =1.0β·10" 7Μ) τ­
ι — • platelets ( E C 5 0 =2.22-10" 7MJ V 
7 6 
- log [PAF] 
Fig. 3. Dose effect curves of PAF on the occlusion rate during filtra­
tion of whole blood, purified PMNs, or platelet rich plasma, respec­
tively (details see text), η = 5, means ± SD. A significant increase in 
the occlusion rate during filtration of whole blood occurred already at 
a PAF-concentration of 2 nM (p = 0.05) 
pensions of various blood cell types, the respective con­
centrations of which were adjusted to those found in 
correspondingly diluted whole blood, showed that the 
microrheological behaviour of the RBCs or lymphocytes 
was not influenced by PAF. In contrast, purified PMNs 
and platelets both occluded the filter pores in the pre­
sence of PAF, and the resulting dose-effect curves, 
taken together, could explain the curve obtained for 
whole blood in good approximation. Staining and 
microscopic examination of the filters finally proved 
38 
Fig. 4. Scanning electron micrographs of filters through which whole 
blood has been passed for 30 s in the presence of a) 2 nM, b) 200 nM 
PAF, and c) in the absence of PAF 
that, in whole blood, PAF selectively stimulates only the 
PMNs and the platelets. During this process, these two 
cell species changed shape in a typical manner. On the 
basis of the E C ^ Q values given in Fig. 3, it can be seen 
that PMNs are stimulated by appreciably lower concen­
trations of PAF than the platelets. Furthermore, under 
the influence of PAF, PMNs and platelets in whole 
blood interacted, and it were the resulting micro-coag-
gregates that finally plugged the capillary pores (Fig. 4a 
and b). The specificity of these interactions was under­
scored by the fact that in the absence of PAF, no cell 
aggregates were to be detected on the surface and in the 
pores of the biologically inert filters (Fig. 4c). 
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Fig. 5. Inhibition of occlusion rate induced by PAF (0.05 μΜ) by 
various concentrations of adenosine or 5'-AMP. Blood samples were 
preincubated for 90 s with the respective inhibitor, and for 60 s with 
PAF. η =5, means ± SD. A highly significant decrease in the occlusion 
-7 -6 
rate occurred already at 10 Μ adenosine and 10 Μ AMP, respec­
tively (p = 0.01) 
Adenosine appreciably suppressed the negative 
effect of PAF on the microrheological properties of 
whole blood, already at physiological plasma concentra­
tions (approx. 2x10 M), and even completely prevented 
it at higher concentrations (Fig. 5). 5'-AMP developed 
an appreciable inhibitory effect only at much higher con­
centrations. With the aid of sensitive HPLC techniques 
this "AMP-effect" could be traced back solely to adeno­
sine, which was formed from 5'-AMP by the action of 
S'-nucleotidase present on the cell membrane of lym­
phocytes and monocytes. Inosine proved to be comple­
tely inert. 
As Fig. 6 reveals, the plasma adenosine concen-
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Fig. 6. Plasma adenosine concentration in (1) whole blood (mixed with 
10 μΜ dipyridamol and 10 μΜ EHNA) in the absence of PAF a) 
prior, b) 1 min after filtration and immediate centrifugation (endo­
thelial cells had no influence on these values); (2a,b) as in (1), but in 
the presence of PAF (1 μΜ); (3) as in (2b), but after subsequent pas­
sage during 1 min through a microcarrier column coated with endo­
thelial cells, η=4, means ± SD 
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tration of whole blood was unaffected by the filtration 
process, since the values prior and after passage of the 
pores were identical. However, blood samples which 
were stimulated with PAF contained appreciably higher 
adenosine concentrations after passage of the pores than 
before, due to stimulated release and degradation of 
adenine nucleotides from the platelets. Interestingly, if 
these samples were subsequently passaged through den­
sely packed endothelial cell cultures, the adenosine con­
centration was further elevated. As relevant control 
experiments reveal, approximately 20% of this nucleo­
side fraction was released from the endothelial cells. 
Discussion 
Filtration techniques have been in use for some time to 
characterise the passive rheological behaviour of blood, 
mainly in the form of purified RBC suspensions [7]. 
However, for a reliable recording of active and rapid 
Ca2+-dependent leukocyte and platelet reactions and 
interactions at a temperature of 37°C, the measuring de­
vices and evaluation procedures described in the litera­
ture are not adequate. This technical limitation has now 
been overcome by the sensitive, electronically controlled 
filtration procedure we have developed. The haema-
tocrit of 6% we selected is of the order of magnitude of 
microhaematocrit values measured in vivo [8]. 
Scanning electron microscopic examinations re­
vealed that PAF can stimulate PMNs and platelets to 
effect highly complex changes in their shape, size, rigi­
dity, adhesivity, and aggregability. As we have demon­
strated, these effects occurred statistically significant 
even at low PAF concentrations around 2nM. Such 
values can be found in arterial blood of CAD-patients 
[9], and are probably even higher in blood under condi­
tions of septicaemia. 
In other studies [10], we have been able to show 
that FMLP, another mediator of acute inflammation, 
selectively activated the PMNs in whole blood, while 
5'-ADP stimulated only the platelets. However, in these 
eases, too - probably mediated by products (e.g. oxygen 
radicals) released secondarily by the stimulated cells -
activation of the respective other cell species soon 
occurred. This close cooperation between PMNs and 
platelets has to date received but little attention in stu­
dies of inflammatory processes. 
In vivo the concentration of PAF is greatest at the 
centre of an inflammatory focus due to its release from 
activated leukocytes and endothelial cells [3], The mo­
ment PAF accumulates in the microcirculation of the 
Inflamed area, it should rapidly induce similar cellular 
reactions as we could demonstrate in vitro. The resulting 
plugging of the capillaries by the blood cells and the de­
crease of flow are then probably very important pre­
conditions for the PMNs and monocytes to attach to the 
vascular wall and to bind to the initially only weakly ex­
pressed adhesion molecules at the endothelium [1]. 
The PAF-activated platelets, on the other hand, 
release ADP and ATP, which can be dephosphorylated 
to adenosine in the intravascular space, but rapidly only 
by the luminal ectornucleotidases of the vascular endo­
thelium. As the blood is distributed within more and 
more microvessels downstream of the focus of inflam­
mation, it is simultaneously being brought into contact 
with an ever increasing endothelial surface. In this way, 
it would be possible in vivo for considerable concentra­
tions of adenosine to build up in the very surrounding of 
the primary focus. Together with other typical endothe­
lial cell release products, such as prostanoids (PGL^, 
P G E ^ PGEo) and nitric oxide (NO) this could prevent 
PMNs and platelets from entering the remaining circu­
lation in an activated state. All these compounds are 
potent vasodilators, and might thus also be responsible 
for the hyperaemia that is typically observed in the mar­
ginal zone surrounding the focus of an inflammation. 
Finally, mediators of acute inflammation, like 
PAF [3], and endothelium-derived inhibitors of leu­
kocytes and platelets, like adenosine [6], have only a 
short half-life in circulating blood. This could contribute 
to explain why, immediately outside the zone of inflam­
mation, physiological perfusion and regulation of the 
blood vessels are again observed. 
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